Goldman Upgrades Comerica To Neutral; Restructuring Uncertain, M&A Deal Best Route

Loading...
Loading...
Goldman Sachs' Ryan Nash upgraded
Comerica IncorporatedCMA
from Sell to Neutral, while raising the price target from $42 to $49.

Nash stated, "CMA has failed to earn its cost of capital" since 2010, but recently the company's decision to hire a consulting firm to explore "strategic alternatives" has the analyst positive on the company.

Related Link: CLSA's Mike Mayo Talks Comerica's Annual Meeting: Management Is "Finally Listening"

In addition to opportunities to improve returns, the company is open to strategic alternatives as well. Major restructuring of the company could raise its return on equity to 10 percent. In a potential M&A deal, Comerica could gain a valuation of $60–$70. The "potential for strategic actions will likely provide downside protection to shares," Nash noted.

Organic Plan

Restructuring would increase returns from 7 percent to 10 percent with expense and revenue initiates and capital optimization. If properly done it could push valuation to $57.

Strategic Plan

With Comerica's history and recent metrics, CMA could "achieve a $60–$70 valuation in a sale," Nash said.

Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorLong IdeasUpgradesPrice TargetAnalyst RatingsTrading IdeasGoldman SachsRyan Nash
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...